Matsui venture capital bill (HR 420) endorsed by BIO in House testimony.
Executive Summary
HR 420 VENTURE CAPITAL INCENTIVES SUPPORTED BY BIO in testimony delivered by Connective Therapeutics CEO Tom Wiggans during a March 19 hearing of the House Ways & Means Committee on the Clinton Administration's FY 1998 budget request. Wiggans endorsed House legislation (HR 420) introduced by Reps. Matsui (D-Calif.), English (R-Penn.) and McCrery (R-La.). The Matsui bill is a reprise of legislation introduced during the 104th Congress ("The Pink Sheet" June 26, 1995, T&G-3).